Estate Planners Group’s CVS Health CVS Stock Holding History

Estate Planners Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-61	Closed	-$4.87K	–	141
2025 Q4	$4.87K	Buy	+61	New	+$4.81K	﹤0.01%	340

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Estate Planners Group's CVS Position: Q1 2026 in Review

Estate Planners Group sold out of CVS Health (CVS) in Q1 2026, closing a stake of 61 shares — an estimated $4.87K sold.

Estate Planners Group first reported a position in CVS in Q4 2025 and held it in 1 quarter. The position peaked at $4.87K in Q4 2025. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Estate Planners Group reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Estate Planners Group sold 61 CVS Health shares in Q1 2026, an estimated $4.87K.
Estate Planners Group first reported a position in CVS Health in Q4 2025 and held it in 1 quarter.
Estate Planners Group's CVS Health position peaked at $4.87K in Q4 2025.
1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.